172 related articles for article (PubMed ID: 37294891)
1. The Potency of Cowpea Mosaic Virus Particles for Cancer In Situ Vaccination Is Unaffected by the Specific Encapsidated Viral RNA.
Jung E; Chung YH; Mao C; Fiering SN; Steinmetz NF
Mol Pharm; 2023 Jul; 20(7):3589-3597. PubMed ID: 37294891
[TBL] [Abstract][Full Text] [Related]
2. Cowpea Mosaic Virus Outperforms Other Members of the Secoviridae as In Situ Vaccine for Cancer Immunotherapy.
Beiss V; Mao C; Fiering SN; Steinmetz NF
Mol Pharm; 2022 May; 19(5):1573-1585. PubMed ID: 35333531
[TBL] [Abstract][Full Text] [Related]
3. In Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma.
Murray AA; Wang C; Fiering S; Steinmetz NF
Mol Pharm; 2018 Sep; 15(9):3700-3716. PubMed ID: 29798673
[TBL] [Abstract][Full Text] [Related]
4. Inactivated Cowpea Mosaic Virus for In Situ Vaccination: Differential Efficacy of Formalin vs UV-Inactivated Formulations.
Jung E; Mao C; Bhatia M; Koellhoffer EC; Fiering SN; Steinmetz NF
Mol Pharm; 2023 Jan; 20(1):500-507. PubMed ID: 36399598
[TBL] [Abstract][Full Text] [Related]
5. Inactivated Cowpea Mosaic Virus in Combination with OX40 Agonist Primes Potent Antitumor Immunity in a Bilateral Melanoma Mouse Model.
Koellhoffer EC; Mao C; Beiss V; Wang L; Fiering SN; Boone CE; Steinmetz NF
Mol Pharm; 2022 Feb; 19(2):592-601. PubMed ID: 34978197
[TBL] [Abstract][Full Text] [Related]
6. Cowpea Mosaic Virus Nanoparticles and Empty Virus-Like Particles Show Distinct but Overlapping Immunostimulatory Properties.
Wang C; Beiss V; Steinmetz NF
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375592
[TBL] [Abstract][Full Text] [Related]
7. In Vivo Fate of Cowpea Mosaic Virus In Situ Vaccine: Biodistribution and Clearance.
Affonso de Oliveira JF; Chan SK; Omole AO; Agrawal V; Steinmetz NF
ACS Nano; 2022 Nov; 16(11):18315-18328. PubMed ID: 36264973
[TBL] [Abstract][Full Text] [Related]
8. The unique potency of Cowpea mosaic virus (CPMV)
Shukla S; Wang C; Beiss V; Cai H; Washington T; Murray AA; Gong X; Zhao Z; Masarapu H; Zlotnick A; Fiering S; Steinmetz NF
Biomater Sci; 2020 Sep; 8(19):5489-5503. PubMed ID: 32914796
[TBL] [Abstract][Full Text] [Related]
9. Plant Viral Nanoparticle Conjugated with Anti-PD-1 Peptide for Ovarian Cancer Immunotherapy.
Gautam A; Beiss V; Wang C; Wang L; Steinmetz NF
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575893
[TBL] [Abstract][Full Text] [Related]
10. Antibody Response against Cowpea Mosaic Viral Nanoparticles Improves
Shukla S; Wang C; Beiss V; Steinmetz NF
ACS Nano; 2020 Mar; 14(3):2994-3003. PubMed ID: 32133838
[TBL] [Abstract][Full Text] [Related]
11. Injectable Hydrogel Containing Cowpea Mosaic Virus Nanoparticles Prevents Colon Cancer Growth.
Nkanga CI; Steinmetz NF
ACS Biomater Sci Eng; 2022 Jun; 8(6):2518-2525. PubMed ID: 35522951
[TBL] [Abstract][Full Text] [Related]
12. Cowpea Mosaic Virus and Natural Killer Cell Agonism for In Situ Cancer Vaccination.
Koellhoffer EC; Steinmetz NF
Nano Lett; 2022 Jul; 22(13):5348-5356. PubMed ID: 35713326
[TBL] [Abstract][Full Text] [Related]
13. In situ vaccination with cowpea mosaic virus elicits systemic antitumor immunity and potentiates immune checkpoint blockade.
Mao C; Beiss V; Ho GW; Fields J; Steinmetz NF; Fiering S
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36460333
[TBL] [Abstract][Full Text] [Related]
14. Cowpea mosaic virus stimulates antitumor immunity through recognition by multiple MYD88-dependent toll-like receptors.
Mao C; Beiss V; Fields J; Steinmetz NF; Fiering S
Biomaterials; 2021 Aug; 275():120914. PubMed ID: 34126409
[TBL] [Abstract][Full Text] [Related]
15. Evidence for participation of RNA 1-encoded elicitor in Cowpea mosaic virus-mediated concurrent protection.
Bruening G; Buzayan JM; Ferreiro C; Lim W
Virology; 2000 Jan; 266(2):299-309. PubMed ID: 10639316
[TBL] [Abstract][Full Text] [Related]
16. In Situ Vaccination of Tumors Using Plant Viral Nanoparticles.
Murray AA; Sheen MR; Veliz FA; Fiering SN; Steinmetz NF
Methods Mol Biol; 2019; 2000():111-124. PubMed ID: 31148013
[TBL] [Abstract][Full Text] [Related]
17.
Chariou PL; Beiss V; Ma Y; Steinmetz NF
Mater Adv; 2021 Mar; 2(5):1644-1656. PubMed ID: 34368764
[TBL] [Abstract][Full Text] [Related]
18. Encapsidation of Viral RNA in
Kruse I; Peyret H; Saxena P; Lomonossoff GP
J Virol; 2019 Jan; 93(2):. PubMed ID: 30355698
[TBL] [Abstract][Full Text] [Related]
19. Injectable Slow-Release Hydrogel Formulation of a Plant Virus-Based COVID-19 Vaccine Candidate.
Nkanga CI; Ortega-Rivera OA; Shin MD; Moreno-Gonzalez MA; Steinmetz NF
Biomacromolecules; 2022 Apr; 23(4):1812-1825. PubMed ID: 35344365
[TBL] [Abstract][Full Text] [Related]
20. Slow-Release Formulation of Cowpea Mosaic Virus for In Situ Vaccine Delivery to Treat Ovarian Cancer.
Czapar AE; Tiu BDB; Veliz FA; Pokorski JK; Steinmetz NF
Adv Sci (Weinh); 2018 May; 5(5):1700991. PubMed ID: 29876220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]